Basel Medical Group Ltd Ordinary Shares(BMGL)

Medical - Care Facilities · Singapore, CE

$3.33+0.16 (+5.05%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T20:35:45.403Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:35:45.403Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 5,213,048
Total debt · period ending 2025-12-31: 7,670,472.0324
Cash · period ending 2025-12-31: 1,043,778.8228
TTM free cash flow · period ending 2025-12-31: N/A

FMP input reference: 3f32b4356dd318fc5fc0a902c875af90b1a094ceb52f500a6b854293a5898a5a

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BMGL EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

BMGL Competitors' EV/FCF Ratio

BMGL

Basel Medical Group Ltd Ordinary Shares

Current

Market Cap

$5.21M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALZN

Alzamend Neuro Inc

vs BMGL

Market Cap

$5.21M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PULM

Pulmatrix, Inc.

vs BMGL

Market Cap

$5.22M

EV/FCF Ratio

N/A

TTM Avg

1.32x

3Y Avg

1.32x

5Y Avg

1.32x

INBS

Intelligent Bio Solutions Inc.

vs BMGL

Market Cap

$5.24M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LNAI

Lunai Bioworks Inc.

vs BMGL

Market Cap

$5.12M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNGX

Soligenix, Inc.

vs BMGL

Market Cap

$5.31M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GELS

Gelteq Limited Ordinary Shares

vs BMGL

Market Cap

$5.32M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LEXX

Lexaria Bioscience Corp.

vs BMGL

Market Cap

$5.35M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LIMN

Liminatus Pharma, Inc. Class A Common Stock

vs BMGL

Market Cap

$4.97M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XBIO

Xenetic Biosciences, Inc.

vs BMGL

Market Cap

$4.86M

EV/FCF Ratio

N/A

TTM Avg

7.51x

3Y Avg

7.51x

5Y Avg

7.51x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Basel Medical Group Ltd Ordinary Shares (BMGL)	$5.21M	N/A	N/A	N/A	N/A
Alzamend Neuro Inc (ALZN)vs ›	$5.21M	N/A	N/A	N/A	N/A
Pulmatrix, Inc. (PULM)vs ›	$5.22M	N/A	1.32x	1.32x	1.32x
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.24M	N/A	N/A	N/A	N/A
Lunai Bioworks Inc. (LNAI)vs ›	$5.12M	N/A	N/A	N/A	N/A
Soligenix, Inc. (SNGX)vs ›	$5.31M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.32M	N/A	N/A	N/A	N/A
Lexaria Bioscience Corp. (LEXX)vs ›	$5.35M	N/A	N/A	N/A	N/A
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$4.97M	N/A	N/A	N/A	N/A
Xenetic Biosciences, Inc. (XBIO)vs ›	$4.86M	N/A	7.51x	7.51x	7.51x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

BMGL EV/FCF Ratio Metrics

BMGL Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics